Uncertainty & Complexity
Has COVID-19 Made Us Smarter?
Living through a pandemic has undoubtedly made us more aware of our health and healthcare policy. But as we struggle...
Read more
Mindfulness in Medical Decisions
Healthcare is a series of decisions, one after another. But most decisions are made reflexively, reiterating familiar patterns of thought....
Read more
Quantum Healthcare
Quantum mechanics has been applied to many fields of science, including biology, leading to recent breakthroughs among longstanding problems within...
Read more
The Heuristics In Our Medical Decisions
The study of medical decision-making is woefully underdeveloped relative to other fields of decision-making, such as quantitative finance and criminal...
Read more
Complexity Will Define the Future of Healthcare
We live in an increasingly complex world - defined by the principles of complexity which emphasize interactions and feedback loops...
Read more
The Psychology of Time
Time is never time alone, it always has an accompanying perception. And the changing perception of COVID-19, as we trudge...
Read more
A Framework to Understand Uncertainty in Healthcare
Today healthcare is seen as more a science than an art, but the progenitors of healthcare saw it as both...
Read more
Fractals May Be The Missing Piece To COVID-19 Projections
Uncertainty and complexity have been the two most prominent features of COVID-19, confounding those who seek to understand and predict...
Read more
Imagination in Healthcare
Is imagination in healthcare important to you?
Read more
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read morePopular
-
National Opioid Settlement Injunction
-
Chronic Care Toolbox
-
The Pharmacy Margin Stress Dashboard: What MedPricer’s NADAC Data Would Actually Show
-
Drug Pricing Transparency in an Era of Political Polarization: What MedPricer’s Data Reveals About a Contested Policy Landscape
-
Employer-Sponsored Insurance Is Breaking Down. Price Data Tells You Where It’s Happening First.
